The Emerging Role of MicroRNAs as a Therapeutic Target for Cardiovascular Disease.
- Published in:
- BioDrugs, 2010, v. 24, n. 3, p. 147, doi. 10.2165/11535860-000000000-00000
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2010 AND VI 24 AND IP 3
Results: 7
1
2
Strategies for In Vivo Delivery of siRNAs.
- Published in:
- BioDrugs, 2010, v. 24, n. 3, p. 195, doi. 10.2165/11534450-000000000-00000
- By:
- Publication type:
- Article
3
Current Status of Vascular Endothelial Growth Factor Inhibition in Age-Related Macular Degeneration.
- Published in:
- BioDrugs, 2010, v. 24, n. 3, p. 183, doi. 10.2165/11318550-000000000-00000
- By:
- Publication type:
- Article
4
Technosphere Insulin: An Inhaled Prandial Insulin Product.
- Published in:
- BioDrugs, 2010, v. 24, n. 3, p. 165, doi. 10.2165/11536700-000000000-00000
- By:
- Publication type:
- Article
5
Dasatinib: Is it All in the Dose?
- Published in:
- BioDrugs, 2010, v. 24, n. 3, p. 157, doi. 10.2165/11535870-000000000-00000
- By:
- Publication type:
- Article
6
Re-Engineering Clostridial Neurotoxins for the Treatment of Chronic Pain.
- Published in:
- BioDrugs, 2010, v. 24, n. 3, p. 173, doi. 10.2165/11534510-000000000-00000
- By:
- Publication type:
- Article
7
Spotlight on Trastuzumab as Adjuvant Treatment in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer.
- Published in:
- BioDrugs, 2010, v. 24, n. 3, p. 207, doi. 10.2165/11204680-000000000-00000
- By:
- Publication type:
- Article